Scientists remain puzzled as to why some individuals taking popular weight loss and diabetes medications such as Ozempic and ...

The following is a summary of “Evaluating lipid-lowering drug targets for full-course diabetic retinopathy,” published in the ...

Abnormal blood vessel growth in the retina can lead to scarring and detachment, causing permanent vision loss. Timely screening and treatment are crucial, yet thousands of newborns go undiagnosed ...

Loss to follow-up higher among men who are Black or Hispanic, or those who must travel farther to care facilities.

A retrospective case series identified nine patients who developed ophthalmic complications during treatment with semaglutide ...

The FDA has approved Susvimo (ranibizumab injection) for the treatment of patients with diabetic macular edema.

Ozempic made headlines after a study came out linking this and similar medications like Wegovy to an eye condition that can cause irreversible damage and permanent vision loss, including total ...

jsiec.org Purpose To determine the prevalence and risk factors for diabetic retinopathy (DR) and sight-threatening diabetic ... of ≥7.0 mmol/L, use of diabetes medication or a previous diagnosis of DM ...

The U.S. Food and Drug Administration has approved Susvimo (ranibizumab) 100 mg/mL for treating diabetic macular edema.

This is a clear case with the MagSafe ring built-in. Allowing you to use all of your favorite MagSafe accessories with the Galaxy S25 Ultra, including ESR’s popular MagSafe battery packs.